electroCore, Inc. Common Stock

ECORNASDAQUSD
9.47 USD
0.18 (1.87%)AT CLOSE (11:59 AM EDT)
9.47
0.01 (0.05%)
POST MARKET (AS OF 04:10 PM EDT)
Post Market
AS OF 04:10 PM EDT
9.47
0.01 (0.05%)
🟢Market: OPEN

Shares of electroCore, Inc. Common Stock (ECOR) are trading at $9.47. The stock presents a mixed profile: our models indicate a Strong Buy for technical indicators, while underlying fundamentals flash a Sell. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, exceptional Return on Equity (529.4%), a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation metrics suggest ECOR is trading at a discount to its peers, earning an "Attractively Valued" rating.

Technical & fundamental data as of Aug 25, 2026.

Open?$9.56
High?$9.97
Low?$9.23
Prev. Close?$9.65
Volume?109.3K
Avg. Volume?83.0K
VWAP?$9.42
Rel. Volume?1.32x
Bid / Ask
Bid?$7.76 × 100
Ask?$11.23 × 100
Spread?$3.47
Midpoint?$9.50
Valuation & Ratios
Market Cap?87.0M
Shares Out?9.0M
Float?5.9M
Float %?65.6%
P/E Ratio?N/A
P/B Ratio?-31.18
EPS?-$1.64
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.
Employees
83
Market Cap
87.0M
Industry
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Listed
2018-06-22
Address
200 FORGE WAY
ROCKAWAY, NJ 07866
Phone: 973-290-0097
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+3/3)
Medium-Term (Wave)? Bullish(+2/3)
Short-Term (Ripple)? Bearish(-2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
0
Momentum?
83
Short Sent.?
80
Piotroski F-Score?2/9Weak
Altman Z-Score?-14.08Distress
Confidence?46%Low
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?5.45%Elevated
Short Interest?322.4K
Days to Cover?2.7
Free Float5.9M
Avg Daily Volume121.1K
Settlement Date2026-08-14
Financial Health
Current Ratio?1.21Adequate
Quick Ratio?1.00Adequate
Cash Ratio?0.73Adequate
Debt/Equity?-2.43Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A
P/B?
S&P
97
-31.18CHEAP
P/S?
Peers
100
S&P
59
2.35CHEAP
P/FCF?
N/A
EV/EBITDA?
S&P
97
-6.2CHEAP
EV/Sales?
Peers
100
S&P
70
2.31CHEAP
Returns & Efficiency
ROE?
Peers
50
S&P
97
529.4%STRONG
ROA?
S&P
3
-86.6%WEAK
Cash Flow & Enterprise
FCF?$-9745000
Enterprise Value?$85.3M
Fundamentals ratios updated end of day